BONE THERAPEUTICS  (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair, fracture prevention and spinal fusion, today announces the 12-month efficacy results from the first cohort of seven1 patients treated with PREOB® in its Phase IIA severe osteoporosis trial. These […]